Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 3
2009 1
2010 2
2011 1
2012 1
2013 2
2014 5
2015 6
2016 2
2017 3
2018 6
2019 8
2020 7
2021 9
2022 10
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Obesity and type 2 diabetes: Also linked in therapeutic options.
Rubio-Almanza M, Cámara-Gómez R, Merino-Torres JF. Rubio-Almanza M, et al. Among authors: merino torres jf. Endocrinol Diabetes Nutr (Engl Ed). 2019 Mar;66(3):140-149. doi: 10.1016/j.endinu.2018.08.003. Epub 2018 Oct 15. Endocrinol Diabetes Nutr (Engl Ed). 2019. PMID: 30337188 Review. English, Spanish.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Clinical Trial.
Surgical and Pharmacological Management of Functioning Pheochromocytoma and Paraganglioma.
García MIDO, Palasí R, Gómez RC, Marco JLP, Merino-Torres JF. García MIDO, et al. Among authors: merino torres jf. In: Mariani-Costantini R, editor. Paraganglioma: A Multidisciplinary Approach [Internet]. Brisbane (AU): Codon Publications; 2019 Jul 2. Chapter 4. In: Mariani-Costantini R, editor. Paraganglioma: A Multidisciplinary Approach [Internet]. Brisbane (AU): Codon Publications; 2019 Jul 2. Chapter 4. PMID: 31294943 Free Books & Documents. Review.
Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study.
García de Lucas MD, Caballero I, Fernández-García JC, Domínguez-Rodríguez M, Moreno-Moreno P, Jiménez-Millán A, Botana-López M, Avilés B, Merino-Torres JF, Soto A, Tejera C, Morales C. García de Lucas MD, et al. Among authors: merino torres jf. Front Endocrinol (Lausanne). 2023 Oct 24;14:1240279. doi: 10.3389/fendo.2023.1240279. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37955013 Free PMC article.
Simultaneous pancreas-kidney transplantation: which graft warns the most?
Giuliani T, Ibáñez JM, Montalvá-Orón E, Robledo AB, Chicote CM, Sanz AH, Ibañez CB, Mizrahi DC, Castelló IB, Torres JFM, Andújar RL. Giuliani T, et al. Among authors: torres jfm. Langenbecks Arch Surg. 2023 May 16;408(1):196. doi: 10.1007/s00423-023-02876-7. Langenbecks Arch Surg. 2023. PMID: 37191721
68 results